Biomedical R&D company that is preparing to begin clinical trials of its donor organ repair technology. By repairing severe warm ischemic damage, the company's technology could expand the window of time for organ recovery, enabling previously unusable organs to repaired and transplanted. This will expand the donor pool to dramatically increase the number of organs that are available for transplantation.
Looking for a particular BREONICS employee's phone or email?
The BREONICS annual revenue was $405000 in 2026.
BREONICS is based in Watervliet, New York.
The NAICS codes for BREONICS are [6219, 62199, 621991, 62, 621].
The SIC codes for BREONICS are [80, 809].